The estimated Net Worth of Bankole A. Johnson is at least $949 mil dollars as of 4 October 2021. Bankole Johnson owns over 200,000 units of Adial Pharmaceuticals, WT EXP 073123 stock worth over $0 and over the last 6 years Bankole sold ADILW stock worth over $948,500.
Sign up
Bankole Johnson ADILW stock SEC Form 4 insiders trading
Bankole has made over 5 trades of the Adial Pharmaceuticals, WT EXP 073123 stock since 2019, according to the Form 4 filled with the SEC. Most recently Bankole sold 200,000 units of ADILW stock worth $0 on 4 October 2021.
The largest trade Bankole's ever made was selling 350,000 units of Adial Pharmaceuticals, WT EXP 073123 stock on 20 August 2020 worth over $423,500. On average, Bankole trades about 92,310 units every 92 days since 2018. As of 4 October 2021 Bankole still owns at least 148,246 units of Adial Pharmaceuticals, WT EXP 073123 stock.
You can see the complete history of Bankole Johnson stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Bankole Johnson's mailing address?
Bankole's mailing address filed with the SEC is 1395 BRICKELL AVE,, SUITE 200, MIAMI,, FL, 33131.
Insiders trading at Adial Pharmaceuticals, WT EXP 073123
Over the last 6 years, insiders at Adial Pharmaceuticals, WT EXP 073123 have traded over $948,500 worth of Adial Pharmaceuticals, WT EXP 073123 stock and bought 344,044 units worth $452,385 . The most active insiders traders include Bankole A. Johnson, William B. Iii Stilley y Kevin Schuyler. On average, Adial Pharmaceuticals, WT EXP 073123 executives and independent directors trade stock every 145 days with the average trade being worth of $0. The most recent stock trade was executed by Kevin Schuyler on 29 September 2023, trading 700 units of ADILW stock currently worth $1,918.
What does Adial Pharmaceuticals, WT EXP 073123's logo look like?
Complete history of Bankole Johnson stock trades at Adial Pharmaceuticals, WT EXP 073123
Adial Pharmaceuticals, WT EXP 073123 executives and stock owners
Adial Pharmaceuticals, WT EXP 073123 executives and other stock owners filed with the SEC include:
-
James W. Jr. Newman,
Director -
Joseph Truluck,
Chief Financial Officer -
Bankole A. Johnson,
Director -
Robertson H. Gilliland,
Director -
Tony Goodman,
Chief Operating Officer -
J. Kermit Anderson,
Director -
Jack W Reich,
Director -
Kevin Schuyler,
Director -
William B. Iii Stilley,
Director -
Cary J Claiborne,
Chief Executive Officer